Lamivudine treatment in patients with decompensated liver disease due to HBeAg negative chronic hepatitis B. A multicenter study.

被引：0
|
作者：
Manolakopoulos, S
Karatapanis, S
Elefsiniotis, J
Goulis, J
Mathou, N
Vlachogiannakos, J
Iliadou, E
Kougioumtzan, A
Economou, M
Tzourmakliotis, D
Avgerinos, A
机构：
[1] Polyclin Gen Hosp, Athens, Greece
[2] Gen Hosp Athens Elpis, Athens, Greece
[3] Elena Venizelou Hosp, Athens, Greece
[4] Evangelismos Gen Hosp, Athens, Greece
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1930
引用
收藏
页码：645A / 645A
页数：1
相关论文
共 50 条
  • [21] Lamivudine for the treatment of chronic hepatitis B.
    Verhelst, D
    Goffin, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08): : 592 - 592
  • [22] Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    Lai, CL
    Shouval, D
    Lok, AS
    Chang, TT
    Cheinquer, H
    Goodman, Z
    DeHertogh, D
    Wilber, R
    Zink, RC
    Cross, A
    Colonno, R
    Fernandes, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1011 - 1020
  • [23] Efficacy of lamivudine in HBeAg-negative chronic hepatitis B
    Rizzetto, M
    JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (04) : 435 - 451
  • [24] Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection
    Manolakopoulos, S
    Karatapanis, S
    Elefsiniotis, J
    Mathou, N
    Vlachogiannakos, J
    Iliadou, E
    Kougioumtzan, A
    Economou, M
    Triantos, C
    Tzourmakliotis, D
    Avgerinos, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (01): : 57 - 63
  • [25] Natural history of extended lamivudine (LAM) treatment in patients with HBeAg negative chronic hepatitis B (CHB).
    Tassopoulos, NC
    Delladetsima, JK
    Anagnostopoulos, GD
    HEPATOLOGY, 2001, 34 (04) : 633A - 633A
  • [26] Natural history of extended lamivudine (LAM) treatment in patients with HBeAg negative chronic hepatitis B (CHB)
    Tassopoulos, N
    Anagnostopoulos, G
    Sypsa, V
    Delladetsima, J
    Hantzakis, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 248 - 248
  • [27] Retherapy with lamivudine in HBeAg-negative chronic hepatitis B patients unresponsive to interferon/peginterferon treatment
    Fedorchenko, S. V.
    Martynovich, T. L.
    Yanchenko, V. I.
    Klimenko, Zh. B.
    Lyashok, O. V.
    VOPROSY VIRUSOLOGII, 2011, 56 (03) : 37 - 40
  • [28] Long-term treatment with lamivudine in HBeAg negative patients with chronic hepatitis B: To switch or not to switch?
    Shouval, Daniel
    JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1219 - 1220
  • [29] Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine
    Sponseller, CA
    Bacon, BR
    Di Bisceglie, AM
    LIVER TRANSPLANTATION, 2000, 6 (06) : 715 - 720
  • [30] A pilot study with lamivudine and famciclovir for the treatment of chronic hepatitis B.
    Kwo, PY
    Shen, H
    Chalasani, N
    Lumeng, L
    Anderson, J
    Paul, J
    HEPATOLOGY, 2000, 32 (04) : 589A - 589A
12345